Prevention of Preeclampsia and Eclampsia

Chesley's Hypertensive Disorders in Pregnancy

Volumn , Issue , 2009, Pages 213-225

  Sibai, Baha M ^a   Gary Cunningham, F ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882484750     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374213-1.00012-4     Document Type: Chapter

References (82)

1. B.M. Sibai (2003) Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 102 181-192.
2. B.M. Sibai, G. Dekker and M. Kupferminc (2005) Preeclampsia. Lancet 365 785-799.
3. A. Conde-Agudelo, J. Villar and M. Lindheimer (2004) World Health Organization Systemic Review of Screening Tests for Preeclampsia. Obstet Gynecol 104 1367-1391.
4. M. Widmer, J. Villar, A. Benigin, et al. (2007) Mapping the theory of preeclampsia and the role of angiogenic factors: A systemic review. Obstet Gynecol 109 168-180.
5. L.C. Chesley (1978) Hypertensive Disorders in Pregnancy. New York: Appleton-Century-Croft
6. E.A.P. Steegers, T.K.A.B. Eskes, H.W. Jongsma and P.R. Hein (1991) Dietary sodium restriction during pregnancy: A historical review. Eur J Obstet Gynecol Reprod Biol 40 83-90.
7. M. Knuist, G.J. Bonsel, H.A. Zondervan and P.E. Treffers (1998) Low sodium diet and pregnancy-induced hypertension: A multi-centre randomized trial. Br J Obstet Gynaecol 105 430-434.
8. C.D. Adair, L. Sanchez-Ramos, D.L. Briones and P. Ogburn (1996) The effect of high dietary N-3 fatty acid supplementation on angiotensin II pressor response in human pregnancy. Am J Obstet Gynecol 74 688-691.
9. M.T.E.W. Bulstra-Ramakers, H.J. Huisjes and G.H.A. Visser (1994) The effects of 3 g eicosapentaenoic acid daily on recurrence of intrauterine growth retardation and pregnancy induced hypertension. Br J Obstet Gynaecol 102 123-126.
10. J.L. Onwude, R.J. Lilford, H. Hjartardottier, et al. (1995) A randomized double blind placebo controlled trial of fish oil in high risk pregnancy. Br J Obstet Gynaecol 109 95-100.
11. J.D. Salvig, S.F. Olsen and N.J. Secher (1996) Effects of fish oil supplementation in late pregnancy on blood pressure: A randomized controlled trial. Br J Obstet Gynaecol 103 529-533.
12. S.F. Olsen, N.J. Secher, A. Tabor, et al. (2000) Randomized clinical trials of fish oil supplementation in high risk pregnancies. BJOG 107 382-395.
13. A.S. Olafsdottir, G.V. Skuladottir, I. Thorsdottir, et al. (2006) Relationship between high consumption of marine fatty acids in early pregnancy and hypertensive disorders in pregnancy. BJOG 113 301-309.
14. M. Makrides, L. Duley and S.F. Olsen (2006) Marine oil, and other prostaglandin precursor supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction. Cochrane Database Syst Rev 3 CD003402.
15. J.M. Belizan, J. Villar and J. Repke (1988) The relationship between calcium intake and pregnancy induced hypertension: Up-to-date evidence. Am J Obstet Gynecol 158 898-902.
16. P. Lopez-Jaramillo, M. Narvaez, R.M. Weigel and R. Yepez (1989) Calcium supplementation reduces the risk of pregnancy-induced hypertension in an Andes population. Br J Obstet Gynaecol 96 648-655.
17. P. Lopez-Jaramillo, M. Narvaez, C. Felix and A. Lopez (1990) Dietary calcium supplementation and prevention of pregnancy hypertension (letter). Lancet 335 293.
18. J. Villar and J. Repke (1990) Calcium supplementation during pregnancy may reduce preterm delivery in high-risk populations. Am J Obstet Gynecol 163 1124-1131.
19. J.M. Belizan, J. Villar, L. Gonzalez, et al. (1991) Calcium supplementation to prevent hypertensive disorders of pregnancy. N Eng J Med 325 1399-1405.
20. L. Sanchez-Ramos, D.K. Briones, A.M. Kaunitz, et al. (1994) Prevention of pregnancy-induced hypertension by calcium supplementation in angiotensin II-sensitive patients. Obstet Gynecol 84 349-353.
21. M. Purwar, H. Kulkarni, V. Motghare and S. Dhole (1996) Calcium supplementation and prevention of pregnancy induced hypertension. J Obstet Gynaecol Res 22 425-430.
22. R.J. Levine, J.C. Hauth, L.B. Curet, et al., the Maternal-Fetal Medicine Units Network (1997) Trial of calcium to prevent preeclampsia. N Eng J Med 337 69-76.
23. P. Lopez-Jaramillo, F. Delgado, P. Jacome, et al. (1997) Calcium supplementation and the risk of preeclampsia in Ecuadorian pregnant teenagers. Obstet Gynecol 90 162-167.
24. C.A. Crowther, J.E. Hiller, B. Pridmore, et al. (1999) Calcium supplementation in nulliparous women for the prevention of pregnancy-induced hypertension, preeclampsia and preterm birth: An Australian randomized trial. Aust NZ J Obstet Gynaecol 39 12-18.
25. J. Villar, H. Abdel-Aleena, M. Merialdi, et al. (2006) World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. Am J Obstet Gynecol 194 639-649.
26. J.A. Herrera, M. Arevalo-Herrera and S. Herrera (1998) Prevention of preeclampsia by linoleic acid and calcium supplementation: A randomized controlled trial. Obstet Gynecol 91 585-590.
27. G.J. Hofmeyr, A.N. Atallah and L. Duley (2006) Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev (3), CD001059
28. P.R. Trumbo and K.C. Ellwood (2007) Supplemental calcium and risk reduction of hypertension, pregnancy-induced hypertension, and preeclampsia: An evidence-based review by the US Food and Drug Administration. Nutr Rev 65 78-87.
29. F.A. Fimerty, J.H. Bucholz and J. Tuckman (1958) Evaluation of chlorothiazide (Diuril) in the toxemias of pregnancy. JAMA 166 141-144.
30. C.E. Flowers, J.E. Grizzle, W.E. Easterling and O.B. Bonner (1962) Chlorothiazide as a prophylaxis against toxemia of pregnancy. A double blind study. Am J Obstet Gynecol 84 919-927.
31. D. Churchill, G.D. Beever, S. Meher and C. Rhodes (2007) Diuretics for preventing preeclampsia. Cochrane Database Syst Rev 24 CD00-4451
32. B.M. Sibai (2002) Chronic hypertension in pregnancy. Obstet Gynecol 100 369-377.
33. E. Abalos, L. Duley, D.W. Steyn and D.J. Henderson-Smart (2007) Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Review (1), CD002252.
34. R.O. Powrie (2007) A 30-year-old woman with chronic hypertension trying to conceive. JAMA 298 1548-1559.
35. M. Moretti, M. Phillips, A. Abouzeid, et al. (2004) Increased breath markers of oxidative stress in normal pregnancy and preeclampsia. Am J Obstet Gynecol 190 1184-1190.
36. M.T. Raijmakers, R. Dechend and L. Poston (2004) Oxidative stress and preeclampsia: rationale for antioxidant clinical trials. Hypertension 44 374-380.
37. L.C. Chappell, P.T. Seed, A.L. Briley, et al. (1999) Effect of antioxidants on the occurrence of preeclampsia in women at increased risk: a randomized trial. Lancet 354 810.
38. D. Beazley, R. Ahokas, J. Livingston, et al. (2005) Vitamin C and E supplementation in women at high risk for preeclampsia: A double-blind, placebo-controlled trial. Am J Obstet Gynecol 192 520-521.
39. L. Poston, A.L. Briley, P.T. Seed, et al. (2006) Vitamins in preeclampsia (VIP) trial consortium, Vitamin C and Vitamin E in pregnant women at risk for preeclampsia: randomized placebo-controlled trial. Lancet 367 1145-1154.
40. A.R. Rumbold, C.A. Crowther, R.R. Haslam, et al. (2006) Supplementation with vitamins C and E and the risk of preeclampsia and perinatal complications. N Eng J Med 354 1796-1806.
41. J.A. Spinnato, S. Freire, J.L.P. de Silva, et al. (2007) Antioxidant therapy to prevent preeclampsia. A randomised controlled trial. Obstet Gynecol 110 1311-1318.
42. J. Villar, M. Purwar, M. Merialdi, N. Zavaleta, N.N. Tien and J. Anthony (2007) WHO randomised trial of vitamin C & E supplementation among women at high risk for preeclampsia and nutritional deficiency. Society of Maternal-Fetal Medicine Abstract # 8. Am J Obstet Gynecol 197 S4.
43. J.S. Moldenhauer, J. Stanek, C. Warshak, et al. (2003) The frequency and severity of placental findings in women with preeclampsia are gestational age dependent. Am J Obstet Gynecol 189 1173-1177.
44. H.C.S. Wallenburg, A. Dekker, J.W. Makovitz and P. Rotmans (1986) Low dose aspirin prevents pregnancy-induced hypertension and preeclampsia in angiotensin-sensitive primigravidae. Lancet 1 1-3.
45. S.N. Caritis, B.M. Sibai, J. Hauth, et al. (1998) Low-dose aspirin to prevent preeclampsia in women at high risk. N Eng J Med 338 701-705.
46. L.M. Askie, D.J. Henderson-Smart and L.A. Stewart on behalf of the Paris Collaborative Group (2007) Antiplatelet agents for the prevention of preeclampsia: A meta-analysis of individual data. Lancet 369 179-198.
47. A. Coomarasamy, H. Honest, S. Papaioannou, et al. (2003) Aspirin for prevention of preeclampsia in women with historical risk factors: A systemic review. Obstet Gynecol
48. M.J. Kupferminc, G. Fait, A. Many, et al. (2001) Low molecular weight heparin for the prevention of obstetric complications in women with thrombophilia. Hypertens Pregnancy 20 35-44.
49. F. Sergio, D.M. Clara, F. Galbriella, et al. (2006) Prophylaxis of recurrent preeclampsia : Low molecular weight heparin plus low-dose aspirin versus low-dose aspirin alone. Hypertens Pregnancy 25 115-127.
50. B.M. Sibai (2005) Diagnosis, prevention, and management of eclampsia. Obstet Gynecol 105 402-410.
51. J.J. Walker (1991) Hypertensive drugs in pregnancy. Hypertens Pregnancy 18 845-872.
52. R.F. Burrows and E.A. Burrows (1995) The feasibility of a control population for a randomized controlled trial of seizure prophylaxis in the hypertensive disorders of pregnancy. Am J Obstet Gynecol 173 929-935.
53. J.M. Alexander, D.D. McIntire, K.J. Leveno and F.G. Cunningham (2006) Selective magnesium sulfate prophylaxis for the prevention of eclampsia in women with gestational hypertension. Obstet Gynecol 108 826-832.
54. M.P. Appleton, T.J. Kuehl, M.A. Raebel, et al. (1991) Magnesium sulfate versus phenytoin for seizure prophylaxis in pregnancy-induced hypertension. Am J Obstet Gynecol 165 907-913.
55. S.A. Friedman, K.H. Lim, C.A. Baker and J.T. Repke (1993) Phenytoin versus magnesium sulfate in preeclampsia: A pilot study. Am J Perinatol 10 233-238.
56. M.W. Atkinson, D. Guinn, J. Owen and J.C. Hauth (1995) Does magnesium sulfate affect the length of labor induction in women with pregnancy-associated hypertension? Am J Obstet Gynecol 173 1219-1222.
57. M.J. Lucas, K.J. Leveno and F.G. Cunningham (1995) A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Eng J Med 333 201-205.
58. A.G. Witlin, S.A. Friedman and B.M. Sibai (1997) The effect of magnesium sulfate therapy on the duration of labor in women with mild preeclampsia at term: A randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol 176 623-627.
59. J.C. Livingston, L.W. Livingston, R. Ramsey, B.C. Mabie and B.M. Sibai (2003) Magnesium sulfate in women with mild preeclampsia: A randomized controlled trial. Obstet Gynecol 101 217-220.
60. H.J. Odendaal and D.R. Hall (1996) Is magnesium sulfate prophylaxis really necessary in patients with severe preeclampsia? J Maternal Fetal Invest 6 14-18.
61. D.R. Hall, J.H. Odendaal and M. Smith (2000) Is prophylactic administration of magnesium sulfate in women with pre-eclampsia indicated prior to labour? Br J Obstet Gynaecol 107 903-908.
62. J. Moodley and V.V. Moodley (1994) Prophylactic anticonvulsant therapy in hypertensive crises of pregnancy – the need for a large randomized trial. Hypertens Pregnancy 13 245-252.
63. E.J. Coetzee, J. Dommisse and J. Anthony (1998) A randomized controlled trial of intravenous magnesium sulfate versus placebo in the management of women with severe pre-eclampsia. Br J Obstet Gynaecol 105 300-303.
64. D. Altman, G. Carroli, L. Duley, et al., Magpie Trial Collaboration Group (2002) Do women with preeclampsia, and their babies, benefit from magnesium sulfate? The Magpie Trial: A randomized placebo-controlled trial. Lancet 359 1877-1890.
65. M. Belfort, J. Anthony and G. Saade the Nimodipine Study Group (1998) Interim report of the nimodipine vs. magnesium sulfate for seizure prophylaxis in severe preeclampsia study: An international, randomized, controlled trial. Am J Obstet Gynecol 178 1s.
66. J.A. Pritchard and S.A. Pritchard (1975) Standardized treatment of 154 consecutive cases of eclampsia. Am J Obstet Gynecol 123 543-552.
67. R.H. Gedekoh, T.T. Hayashi and H.M. MacDonald (1981) Eclampsia at Magee-Women's Hospital 1970 to 1980. Am J Obstet Gynecol 140 86-96.
68. J.A. Pritchard, F.G. Cunningham and S.A. Pritchard (1984) The Parkland Memorial Hospital protocol for treatment of eclampsia: Evaluation of 245 cases. Am J Obstet Gynecol 148 951-963.
69. B.M. Sibai and J. Ramanathan (1992) The case for magnesium sulfate in preeclampsia-eclampsia. Int J Obstet Anesth 1 167-175.
70. Which anticonvulsant for women with eclampsia: Evidence from the Collaborative Eclampsia Trial. Lancet. 1995;345:1455–63.
71. J. Dommisse (1990) Phenytoin sodium and magnesium sulfate in the management of eclampsia. Br J Obstet Gynaecol 97 104-109.
72. C. Crowther (1990) Magnesium sulfate versus diazepam in the management of eclampsia: A randomized controlled trial. Br J Obstet Gynaecol 97 110-117.
73. A.K. Bhalla, G.I. Dhall and K. Dhall (1994) A safer and more effective treatment regimen for eclampsia. Aust NZ J Obstet Gynecol 34 144-148.
74. Friedman SA, Schiff E, Kao L, Sibai BM. Phenytoin versus magnesium sulfate in patients with eclampsia: Preliminary results from a randomized trial. Poster presented at 15th Annual Meeting of the Society of Perinatal Obstetricians, Atlanta; January 23–28, 1995 (abstr 452). Am J Obstet Gynecol. 1995;172:384, pt 2.
75. A. Richards, L. Stather-Dunn and J. Moodley (1985) Cardio-pulmonary arrest after the administration of magnesium sulfate. S Afr Med J 67 145.
76. McCubbin JH, Sibai BM, Abdella TN, Anderson GD. Cardio-pulmonary arrest due to maternal hypermagnesiumia. Lancet. 198;ii:1058.
77. V.R. Bohman and D.B. Cotton (1990) Supralethal magnesemia with patient survival. Obstet Gynecol 76 984-986.
78. M.G. Ascarelli, V. Johnson, W.L. May, et al. (1998) Individually determined postpartum magnesium sulfate therapy with clinical parameters to safely and cost-effectively shorten treatment for pre-eclampsia. Am J Obstet Gynecol 179 952-956.
79. C.M. Isler, P.S. Barrilleaux, B.K. Rinehart, et al. (2003) Postpartum seizure prophylaxis: using maternal clinical parameters to guide therapy. Obstet Gynecol 101 66-69.
80. M.F. Fontenot, D.F. Lewis, J.B. Frederick, et al. (2005) A prospective randomized trial of magnesium sulfate in severe preeclampsia: Use of diuresis as a clinical parameter to determine the duration of postpartum therapy. Am J Obstet Gynecol 192 1788-1793.
81. H.M. Ehrenberg and B.M. Mercer (2006) Abbreviated postpartum magnesium sulfate therapy for women with mild preeclampsia. Obstet Gynecol 108 833-838.
82. V. Dayicioglu, Z. Sahinoglu, E. Kol, et al. (2003) The use of standard dose of magnesium sulfate in prophylaxis of eclamptic seizures: do body mass index alterations have any effect on success? Hypertens Pregnancy 22 257-265.